Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's divalproex
sodium-delayed-release tablets 500 mg tablets to Abbott's Depakote® 500 mg tablets following
a single, oral 500 mg (1 x 500 mg) dose administration under fasting conditions.